Related Experiment Video
Updated: Jan 20, 2026
High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes
Published on: July 25, 2015
Successful Conversion Surgery after Zolbetuximab-Based Chemotherapy for Claudin 18.2-Positive Gastric Cancer with
Sadaki Shirao1, Takaaki Arigami1, Daisuke Matsushita1
1Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Introduction:
Zolbetuximab, a monoclonal antibody targeting claudin (CLDN) 18.2, has been approved as a first-line treatment for patients with human epidermal growth factor receptor 2 (HER2)-negative and CLDN-positive advanced gastric cancer. Conversion surgery following chemotherapy has emerged as a promising strategy for improving outcomes in patients with stage IV gastric cancer. Herein, we report a case of CLDN-positive gastric cancer with peritoneal dissemination and cervical lymph node metastasis that was successfully treated with subtotal gastrectomy (sTG) following zolbetuximab-based chemotherapy.
Case Presentation:
A 73-year-old male was diagnosed with HER2-negative, CLDN-positive gastric cancer, accompanied by peritoneal dissemination and cervical lymph node metastasis. He received 6 cycles of zolbetuximab in combination with capecitabine and oxaliplatin as first-line chemotherapy. Primary tumor, peritoneal lesions, and lymph node metastases exhibited marked regression, including complete resolution of the metastatic cervical lymph nodes. Complete response was achieved according to the Response Evaluation Criteria for Solid Tumors. After confirming the disappearance of the peritoneal dissemination, the patient underwent sTG with D2 lymphadenectomy. Histopathological examination revealed a grade 2 therapeutic response and no residual lymph node metastasis. The postoperative course was uneventful, and the patient remained recurrence-free for 5 months after the conversion surgery.
Conclusions:
Zolbetuximab-based chemotherapy followed by conversion surgery is a promising therapeutic strategy for patients with CLDN-positive advanced gastric cancer.
Related Concept Videos
10:02High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
08:06Lymph Node Exam
The lymphatic system has two main functions: to return extracellular fluid back to the venous circulation and to expose antigenic substances to the immune system. As the collected fluid passes through lymphatic channels on its way back to the systemic circulation, it encounters multiple nodes consisting of highly concentrated clusters of...
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
10:58Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer